Effect of SARS-CoV-2 Infection on Endovascular Thrombectomy Outcomes-Data from the Florida Stroke Registry.

Hayes B Fountain, Ian Ramsay, Ruijie Yin, Ahmed Abdelsalam, Michael Silva, David Z Rose, Angus Jameson, Ying Hao, Ayham Alkhachroum, Carolina M Gutierrez, Victor J Del Brutto, Robert M Starke, Tanja Rundek, Hannah Gardener, Jose G Romano, Negar Asdaghi
{"title":"Effect of SARS-CoV-2 Infection on Endovascular Thrombectomy Outcomes-Data from the Florida Stroke Registry.","authors":"Hayes B Fountain, Ian Ramsay, Ruijie Yin, Ahmed Abdelsalam, Michael Silva, David Z Rose, Angus Jameson, Ying Hao, Ayham Alkhachroum, Carolina M Gutierrez, Victor J Del Brutto, Robert M Starke, Tanja Rundek, Hannah Gardener, Jose G Romano, Negar Asdaghi","doi":"10.3174/ajnr.A8673","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and purpose: </strong>Endovascular thrombectomy outcomes are impacted by changes in stroke systems of care. During the pandemic, SARS-CoV-2 positive status had major implications on hospital arrival and treatment models of non-COVID-related hospital admissions. Using the Florida Stroke Registry, we compared the rates of in-hospital death and discharge outcomes of patients treated with endovascular thrombectomy who tested positive for SARS-CoV-2 infection during their hospitalization.</p><p><strong>Materials and methods: </strong>Data from Get with the Guidelines-Stroke hospitals participating in the Florida Stroke Registry during the COVID pandemic from March 2020 to December 2022 were reviewed to identify endovascular thrombectomy patients with coding for SARS-CoV-2 testing during their hospital stay. Associations between SARS-CoV-2 status and favorable endovascular thrombectomy outcomes of mRS (0-2) at discharge, discharge to home or rehabilitation center, symptomatic intracerebral hemorrhage, in-hospital mortality, and independent ambulation at discharge were examined by using multivariate logistic regression modeling adjusting for demographics, vascular risk factors, and clinical characteristics. Temporal analyses were used to compare outcomes across the study period.</p><p><strong>Results: </strong>A total of 8184 patients underwent endovascular thrombectomy (median age 71.1 years, women 49.7%, mean NIHSS 14). Of these, 180 (2.20%) were SARS-CoV-2 positive. Compared with SARS-CoV-2 negative endovascular thrombectomy patients, those who tested positive were younger, more frequently men, but with comparable stroke severity at presentation. In multivariable analysis, adjusting for baseline differences and confounding variables, there was a 33% lower likelihood of being discharged to home/inpatient rehab (OR = 0.67, 95% CI: 0.49-0.93), 65% higher odds of in-hospital death (OR = 1.65, 95% CI: 1.06-2.58), as well as a 91% less chance of having a high mRS (>2) at discharge (OR = 0.15, 95% CI: 0.04-0.60) for patients with positive SARS-CoV-2 infection. However, a similar risk of symptomatic intracerebral hemorrhage was present compared with SARS-CoV-2 negative patients (OR = 0.97, 95% CI: 0.50-1.88). Temporal analysis of SARS-CoV-2 positive patients showed no significant differences.</p><p><strong>Conclusions: </strong>In this large multicenter stroke registry, despite comparable clinical presentation and treatment timelines, SARS-CoV2 positive status negatively impacted thrombectomy outcomes.</p>","PeriodicalId":93863,"journal":{"name":"AJNR. American journal of neuroradiology","volume":" ","pages":"1374-1378"},"PeriodicalIF":0.0000,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"AJNR. American journal of neuroradiology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3174/ajnr.A8673","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background and purpose: Endovascular thrombectomy outcomes are impacted by changes in stroke systems of care. During the pandemic, SARS-CoV-2 positive status had major implications on hospital arrival and treatment models of non-COVID-related hospital admissions. Using the Florida Stroke Registry, we compared the rates of in-hospital death and discharge outcomes of patients treated with endovascular thrombectomy who tested positive for SARS-CoV-2 infection during their hospitalization.

Materials and methods: Data from Get with the Guidelines-Stroke hospitals participating in the Florida Stroke Registry during the COVID pandemic from March 2020 to December 2022 were reviewed to identify endovascular thrombectomy patients with coding for SARS-CoV-2 testing during their hospital stay. Associations between SARS-CoV-2 status and favorable endovascular thrombectomy outcomes of mRS (0-2) at discharge, discharge to home or rehabilitation center, symptomatic intracerebral hemorrhage, in-hospital mortality, and independent ambulation at discharge were examined by using multivariate logistic regression modeling adjusting for demographics, vascular risk factors, and clinical characteristics. Temporal analyses were used to compare outcomes across the study period.

Results: A total of 8184 patients underwent endovascular thrombectomy (median age 71.1 years, women 49.7%, mean NIHSS 14). Of these, 180 (2.20%) were SARS-CoV-2 positive. Compared with SARS-CoV-2 negative endovascular thrombectomy patients, those who tested positive were younger, more frequently men, but with comparable stroke severity at presentation. In multivariable analysis, adjusting for baseline differences and confounding variables, there was a 33% lower likelihood of being discharged to home/inpatient rehab (OR = 0.67, 95% CI: 0.49-0.93), 65% higher odds of in-hospital death (OR = 1.65, 95% CI: 1.06-2.58), as well as a 91% less chance of having a high mRS (>2) at discharge (OR = 0.15, 95% CI: 0.04-0.60) for patients with positive SARS-CoV-2 infection. However, a similar risk of symptomatic intracerebral hemorrhage was present compared with SARS-CoV-2 negative patients (OR = 0.97, 95% CI: 0.50-1.88). Temporal analysis of SARS-CoV-2 positive patients showed no significant differences.

Conclusions: In this large multicenter stroke registry, despite comparable clinical presentation and treatment timelines, SARS-CoV2 positive status negatively impacted thrombectomy outcomes.

SARS-CoV2 感染对血管内血栓切除术结果的影响--来自佛罗里达州中风登记处的数据。
背景和目的:血管内血栓切除术的结果受卒中护理系统变化的影响。在大流行期间,SARS-CoV2阳性状态对非covid相关住院患者的入院和治疗模式具有重大影响。使用佛罗里达卒中登记处,我们比较了在住院期间检测为SARS-CoV2感染阳性的血管内取栓治疗患者的住院死亡率和出院结果。材料和方法:回顾2020年3月至2022年12月COVID大流行期间参与佛罗里达州卒中登记的卒中医院的数据,以确定住院期间编码SARS-CoV2检测的血管内血栓切除术患者。采用多因素logistic回归模型对人口统计学、血管危险因素和临床特征进行调整,研究了SARS-CoV2状态与出院时mRS(0-2)、出院时家中或康复中心、症状性脑出血、住院死亡率和出院时独立行走的良好血管内取栓结果之间的关系。时间分析用于比较整个研究期间的结果。结果:8184例患者行血管内取栓术(中位年龄71.1岁,女性50%,平均NIHSS 14),其中180例(2.2%)为SARS-CoV2阳性。与SARS-CoV2血管内血栓切除术阴性患者相比,检测阳性的患者更年轻,更常见的是男性,但在就诊时卒中严重程度相当。在多变量分析中,调整基线差异和混杂变量后,SARS-CoV2感染阳性的患者出院回家/住院康复的可能性降低33% (OR=0.67, 95% CI=(0.49-0.93)),住院死亡的可能性增加65% (OR=1.65, 95% CI=(1.06-2.58)),出院时高mRS (bbb2)的可能性降低85% (OR=0.15, 95% CI=(0.04-0.60))。然而,与SARS-CoV2阴性患者相比,出现症状性脑出血的风险相似(OR=0.97, 95% CI=(0.501.88))。SARS-CoV2阳性患者的时间分析无显著差异。结论:在这个大型多中心卒中登记中,尽管临床表现和住院治疗时间表具有可比性,但SARS-CoV2阳性状态对取栓结果有负面影响。缩写:AIS =急性缺血性中风;LVO =大血管闭塞;EVT =血管内血栓切除术;佛罗里达中风登记处;症状性脑出血。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信